Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share Price

Price 0.27p on 10-04-2026 at 11:00:15
Change 0.00p 0%
Buy 0.28p
Sell 0.26p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 980,795.00 at 0.2615p
Day's Volume: 1,175,424
Last Close: 0.27p
Open: 0.27p
ISIN: GB00BMD1Z199
Day's Range 0.27p - 0.27p
52wk Range: 0.1095p - 0.395p
Market Capitalisation: £18.38m
VWAP: 0.262596p
Shares in Issue: 6.81b

Sector: Medicine and Biotech

Solvonis Therap (SVNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 980,795 0.2615p Ordinary
 10:39:33 - 10-Apr-26
Sell* 50,000 0.2611p Ordinary
 09:32:29 - 10-Apr-26
Unknown* 23,078 0.27p Negotiated Trade
 09:18:03 - 10-Apr-26
Sell* 22,554 0.26p SI Trade
 08:43:04 - 10-Apr-26
Buy* 15,124 0.28p SI Trade
 08:43:04 - 10-Apr-26
Buy* 366 0.28p SI Trade
 08:43:04 - 10-Apr-26
Buy* 742 0.28p SI Trade
 08:43:04 - 10-Apr-26
Buy* 5,314 0.28p SI Trade
 08:43:04 - 10-Apr-26
Sell* 649 0.26p SI Trade
 08:43:04 - 10-Apr-26
Buy* 307 0.28p SI Trade
 08:43:04 - 10-Apr-26
See more Solvonis Therap trades

Solvonis Therap (SVNS) Share Price History

Time period:
to
Date Open High Low Close Volume
9th Apr 2026 (Thu) 0.27 0.27 0.27 0.27 25,554,471
8th Apr 2026 (Wed) 0.27 0.27 0.27 0.27 22,989,698
7th Apr 2026 (Tue) 0.265 0.27 0.27 0.27 68,996,156
6th Apr 2026 (Mon) 0.26 0.26 0.26 0.26 0
3rd Apr 2026 (Fri) 0.26 0.26 0.26 0.26 0
2nd Apr 2026 (Thu) 0.24 0.26 0.23 0.26 75,340,170
1st Apr 2026 (Wed) 0.245 0.245 0.235 0.24 18,253,404
31st Mar 2026 (Tue) 0.26 0.245 0.24 0.245 16,817,151
30th Mar 2026 (Mon) 0.25 0.25 0.24 0.25 11,457,805
27th Mar 2026 (Fri) 0.24 0.25 0.235 0.25 31,124,469
26th Mar 2026 (Thu) 0.23 0.245 0.23 0.24 52,877,921
25th Mar 2026 (Wed) 0.24 0.252 0.23 0.23 28,852,441
24th Mar 2026 (Tue) 0.216 0.231 0.216 0.231 77,053,096
23rd Mar 2026 (Mon) 0.24 0.23 0.21 0.21 31,199,511
20th Mar 2026 (Fri) 0.24 0.25 0.235 0.235 4,117,621
19th Mar 2026 (Thu) 0.24 0.24 0.24 0.24 47,626,956
18th Mar 2026 (Wed) 0.25 0.24 0.24 0.24 17,604,274
17th Mar 2026 (Tue) 0.255 0.25 0.245 0.245 7,408,623
16th Mar 2026 (Mon) 0.25 0.255 0.24 0.24 53,484,417
13th Mar 2026 (Fri) 0.23 0.25 0.23 0.25 50,551,097
12th Mar 2026 (Thu) 0.215 0.23 0.23 0.23 71,052,043
11th Mar 2026 (Wed) 0.225 0.225 0.215 0.215 26,352,912
10th Mar 2026 (Tue) 0.23 0.23 0.225 0.225 24,051,268
See more Solvonis Therap price history

Solvonis Therap (SVNS) Regulatory News

Date Source Headline
8th Apr 2026 7:00 am RNS Granted U.S. Patent from PTSD Discovery Programme
31st Mar 2026 7:00 am RNS Granted U.S. Patent from PTSD Discovery Programme
10th Mar 2026 7:00 am RNS SVN-114 selected for PTSD discovery programme
28th Jan 2026 7:00 am RNS Expansion of SVN-015 into depression
7th Jan 2026 7:00 am RNS US Patent allowance for PTSD discovery programme
22nd Dec 2025 7:00 am RNS Research and Development Update - Q4 2025
22nd Dec 2025 7:00 am RNS Research and Development Update – Q4 2025
3rd Dec 2025 7:00 am RNS SVN-015 accepted into US NIDA funded programme
31st Oct 2025 3:59 pm RNS Total Voting Rights
31st Oct 2025 7:00 am RNS Corporate Structure Update and Issue of Options
See more Solvonis Therap regulatory news

Solvonis Therap (SVNS) Share News

IN BRIEF: Solvonis Therapeutics hails US patent from PTSD programme

8th Apr 2026 14:31

Solvonis Therapeutics PLC - London-based biopharmaceutical company, focused on central nervous system disorders - Celebrates second US patent by United States Patent & Trademark Office, covering a further monoamine modulator compound series arising from its proprietary post-traumatic stress disorder discovery programme. The patent, U.S. Patent No. 12,595,269, was issued on Tuesday. On March 31, the company had announced the first such patent, U.S. Patent No. 12,590,077. Read More

EARNINGS AND TRADING: Ondine trial on track; Ensilica's contract wins

10th Mar 2026 16:34

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: EnSilica hails "solid" half-year; Aptamer revenue up

7th Jan 2026 11:43

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

SMALL-CAP WINNERS & LOSERS: Solvonis gets US patent; Liontrust falls

7th Jan 2026 10:49

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday. Read More

SMALL-CAP WINNERS & LOSERS: Defence Holdings hails AI momentum

22nd Dec 2025 10:12

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

See more Solvonis Therap news
FTSE 100 Latest
Value10,638.25
Change34.77

Login to your account

Forgot Password?

Not Registered